Poster - Bedaquiline Use for DR-TB Treatment: Interim Result of Its Implementation in Indonesia


Until 2015 Indonesia did not have effective treatment options for patients with Pre-XDR (extensively drug-resistant TB) or XDR-TB. WHO published guidance in 2013 stipulating the use under research conditions and pharmacovigilance of Bedaquiline (BDQ) for treatment in patients with (pre-) XDR-TB and MDR-TB patients with intolerance to drugs in the conventional treatment regimen. Indonesia started the use of BDQ in September 2015 with cohort event monitoring. This paper describes the interim results of this Bedaquiline implementation study in Indonesia

Pengguna : Petugas Kesehatan, Publik
Topik : Riset Operasional
Tipe : Tools
Format : Teks
Tahun : 2018